Neha Singh

580 total citations
21 papers, 355 citations indexed

About

Neha Singh is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Neha Singh has authored 21 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 7 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Neha Singh's work include Cancer Mechanisms and Therapy (7 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (2 papers) and Enzyme function and inhibition (2 papers). Neha Singh is often cited by papers focused on Cancer Mechanisms and Therapy (7 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (2 papers) and Enzyme function and inhibition (2 papers). Neha Singh collaborates with scholars based in United States, India and Australia. Neha Singh's co-authors include Andrew S. Kraft, Sathish K.R. Padi, Jin H. Song, Jagat R. Kanwar, Kōichi Okumura, Noel A. Warfel, Virginie Olive, Yagna Jarajapu, Wei Duan and Richard L. Kennedy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Neha Singh

19 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neha Singh United States 12 178 87 83 46 41 21 355
Yunping Lu China 10 266 1.5× 34 0.4× 107 1.3× 20 0.4× 64 1.6× 22 406
Jiayi Lin China 15 348 2.0× 21 0.2× 149 1.8× 27 0.6× 81 2.0× 45 580
Jian Wei China 10 236 1.3× 25 0.3× 130 1.6× 86 1.9× 61 1.5× 14 486
Shaomin Che China 12 155 0.9× 21 0.2× 112 1.3× 23 0.5× 57 1.4× 17 355
Tania Fontanil Spain 14 186 1.0× 15 0.2× 76 0.9× 20 0.4× 106 2.6× 22 460
Patrycja Sujka‐Kordowska Poland 11 192 1.1× 24 0.3× 81 1.0× 19 0.4× 53 1.3× 27 335
Mohamed Hammad United States 13 210 1.2× 28 0.3× 92 1.1× 8 0.2× 71 1.7× 29 426
Jianing Hou China 11 184 1.0× 23 0.3× 31 0.4× 17 0.4× 59 1.4× 25 395
Zizhuo Li China 11 135 0.8× 26 0.3× 37 0.4× 8 0.2× 44 1.1× 24 268

Countries citing papers authored by Neha Singh

Since Specialization
Citations

This map shows the geographic impact of Neha Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neha Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neha Singh more than expected).

Fields of papers citing papers by Neha Singh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neha Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neha Singh. The network helps show where Neha Singh may publish in the future.

Co-authorship network of co-authors of Neha Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Neha Singh. A scholar is included among the top collaborators of Neha Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neha Singh. Neha Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singh, Neha, et al.. (2025). CLO25-090: MiR-31 as a Predictive Biomarker of Cetuximab Efficacy in Metastatic Colorectal Cancer Patients. Journal of the National Comprehensive Cancer Network. 23(3.5). 1 indexed citations
2.
Barwal, Tushar Singh, et al.. (2025). High prevalence of methotrexate intolerance in rheumatoid arthritis patients: a cross-sectional study. BMC Rheumatology. 9(1). 89–89.
3.
Kaur, Ramandeep, et al.. (2024). Rapid detection of porcine sapelovirus by reverse transcription recombinase polymerase amplification assay. Molecular Biology Reports. 51(1). 178–178. 2 indexed citations
4.
Singh, Neha, et al.. (2023). Declining high-impact clinical publication rate: A potential contributor to health disparities among persons with developmental and intellectual disabilities. SHILAP Revista de lepidopterología. 12(9). 1871–1878. 3 indexed citations
5.
Sun, Ching-Fang, et al.. (2023). Factitious dermatitis in children and adolescents is highly comorbid with psychiatric disorders. Journal of Psychosomatic Research. 166. 111170–111170. 1 indexed citations
7.
Singh, Neha, Kanisht Batra, Deepika Chaudhary, et al.. (2022). Prevalence of porcine viral respiratory diseases in India. Animal Biotechnology. 34(4). 1642–1654. 3 indexed citations
8.
Jain, Udit, et al.. (2022). Seroprevalence and Molecular Detection of Bovine Brucellosis. Indian Journal of Animal Research.
9.
Padi, Sathish K.R., Neha Singh, Marina Cardó‐Vila, et al.. (2021). EDC3 phosphorylation regulates growth and invasion through controlling P‐body formation and dynamics. EMBO Reports. 22(4). e50835–e50835. 29 indexed citations
10.
Singh, Neha, Valerie Calvert, Emanuel F. Petricoin, et al.. (2020). PIM Kinase Inhibitors Block the Growth of Primary T-cell Acute Lymphoblastic Leukemia: Resistance Pathways Identified by Network Modeling Analysis. Molecular Cancer Therapeutics. 19(9). 1809–1821. 4 indexed citations
11.
Padi, Sathish K.R., Neha Singh, Virginie Olive, et al.. (2019). Phosphorylation of DEPDC5, a component of the GATOR1 complex, releases inhibition of mTORC1 and promotes tumor growth. Proceedings of the National Academy of Sciences. 116(41). 20505–20510. 18 indexed citations
12.
Song, Jin H., Neha Singh, Sathish K.R. Padi, et al.. (2018). Mechanisms Behind Resistance to PI3K Inhibitor Treatment Induced by the PIM Kinase. Molecular Cancer Therapeutics. 17(12). 2710–2721. 38 indexed citations
13.
Toth, Rachel K., Alva G. Sainz, Neha Singh, et al.. (2017). Hypoxia-Inducible PIM Kinase Expression Promotes Resistance to Antiangiogenic Agents. Clinical Cancer Research. 24(1). 169–180. 43 indexed citations
14.
Padi, Sathish K.R., Ningfei An, Ritu Pandey, et al.. (2017). Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset. Oncotarget. 8(18). 30199–30216. 32 indexed citations
15.
Singh, Neha, Shrinidh Joshi, Lirong Guo, et al.. (2015). ACE2/Ang-(1–7)/Mas axis stimulates vascular repair-relevant functions of CD34+cells. American Journal of Physiology-Heart and Circulatory Physiology. 309(10). H1697–H1707. 32 indexed citations
16.
Singh, Neha, Goutham Vasam, Rahul D. Pawar, & Yagna Jarajapu. (2014). Angiotensin-(1-7) Reverses Angiogenic Dysfunction in Corpus Cavernosum by Acting on the Microvasculature and Bone Marrow–Derived Cells in Diabetes. The Journal of Sexual Medicine. 11(9). 2153–2163. 16 indexed citations
17.
Dawar, Swati, Neha Singh, Jagat R. Kanwar, et al.. (2013). Multifunctional and multitargeted nanoparticles for drug delivery to overcome barriers of drug resistance in human cancers. Drug Discovery Today. 18(23-24). 1292–1300. 56 indexed citations
18.
Kanwar, Jagat R. & Neha Singh. (2011). Role of Nanomedicine in Reversing Drug Resistance Mediated by ATP Binding Cassette Transporters and P-Glycoprotein in Melanoma. Nanomedicine. 6(4). 701–714. 12 indexed citations
19.
Modgil, Amit, Qi Zhang, Ajeeth K. Pingili, et al.. (2011). Angiotensin-(1–7) attenuates the chronotropic response to angiotensin II via stimulation of PTEN in the spontaneously hypertensive rat neurons. American Journal of Physiology-Heart and Circulatory Physiology. 302(5). H1116–H1122. 15 indexed citations
20.
Yao, Fanrong, Amit Modgil, Qi Zhang, et al.. (2010). Pressor Effect of Apelin-13 in the Rostral Ventrolateral Medulla: Role of NAD(P)H Oxidase-Derived Superoxide. Journal of Pharmacology and Experimental Therapeutics. 336(2). 372–380. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026